Trial Governance - Principal Investigators

Laura Mauri, M.D., M.Sc., principal investigator

Dr. Mauri is an interventional cardiologist in the Division of Cardiovascular Medicine at the Brigham and Women's Hospital in Boston, Massachusetts and assistant professor of Medicine at Harvard Medical School. Dr. Mauri also serves as the chief scientific officer at Harvard Clinical Research Institute (HCRI). Dr. Mauri has a history of innovative clinical research in the field of percutanous coronary intervention and leadership of collaborative research among academic groups, industry and U.S. FDA. Her particular expertise is in the use of statistical methods in clinical research, specifically in interventional cardiology. Her work, presented at U.S. FDA advisory panel meetings, several late-breaking clinical trials sessions at the American Heart Association and American College of Cardiology, and in journals such as Circulation and New England Journal of Medicine, have formed a reference point for the evaluation of safety in drug-eluting stents. She is a graduate of Harvard College Harvard Medical School, and the Harvard School of Public Health.

Dean Kereiakes, M.D., co-principal investigator

In addition to his clinical practice, Dr. Kereiakes serves as medical director of The Christ Hospital Heart and Vascular Center and medical director of the Carl and Edyth Lindner Center for Research and Education in Cincinnati, Ohio. He is a professor of Clinical Medicine at Ohio State University. Dr. Kereiakes’s accomplishments include being a previous section editor for Circulation, the official medical journal of the American Heart Association and Editorial Board member for The Journal of the American College of Cardiology, The American Heart Journal, The American Journal of Cardiology, The Journal of Invasive Cardiology and Reviews in Cardiovascular Medicine. He has participated in more than 800 clinical research protocols and has contributed to more than 600 peer reviewed medical publications.